| Fidaxomicin versus Vancomycin for Clostridium difficile Infection TJ Louie, MA Miller, KM Mullane, K Weiss, A Lentnek, Y Golan, S Gorbach, ... New England Journal of Medicine 364 (5), 422-431, 2011 | 1904 | 2011 |
| Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial OA Cornely, DW Crook, R Esposito, A Poirier, MS Somero, K Weiss, ... The Lancet infectious diseases 12 (4), 281-289, 2012 | 875 | 2012 |
| Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults C Rotstein, G Evans, A Born, R Grossman, RB Light, S Magder, ... Canadian Journal of Infectious Diseases and Medical Microbiology 19, 19-53, 2008 | 420 | 2008 |
| Fidaxomicin Versus Vancomycin for Clostridium difficile Infection: Meta-analysis of Pivotal Randomized Controlled Trials DW Crook, AS Walker, Y Kean, K Weiss, OA Cornely, MA Miller, ... Clinical Infectious Diseases 55 (suppl_2), S93-S103, 2012 | 305 | 2012 |
| Efficacy of Fidaxomicin Versus Vancomycin as Therapy for Clostridium difficile Infection in Individuals Taking Concomitant Antibiotics for Other Concurrent Infections KM Mullane, MA Miller, K Weiss, A Lentnek, Y Golan, PS Sears, YK Shue, ... Clinical infectious diseases 53 (5), 440-447, 2011 | 302 | 2011 |
| Tolevamer, a Novel Nonantibiotic Polymer, Compared with Vancomycin in the Treatment of Mild to Moderately Severe Clostridium difficile–Associated Diarrhea TJ Louie, J Peppe, CK Watt, D Johnson, R Mohammed, G Dow, K Weiss, ... Clinical infectious diseases 43 (4), 411-420, 2006 | 292 | 2006 |
| Effect of a Fermented Milk Combining Lactobacillus Acidophilus CL1285 and Lactobacillus Casei in the Prevention of Antibiotic-Associated Diarrhea: A … M Beausoleil, N Fortier, S Guénette, A L’Ecuyer, M Savoie, M Franco, ... Canadian Journal of Gastroenterology and Hepatology 21, 732-736, 2007 | 266 | 2007 |
| Outbreak of Salmonella serotype Saintpaul infections associated with multiple raw produce items--United States, 2008. J Jungk, J Baumbach, M Landen, LK Gaul, L Alaniz, T Dang, EA Miller, ... MMWR: Morbidity & Mortality Weekly Report 57 (34), 2008 | 197 | 2008 |
| Canadian guidelines for the management of acute exacerbations of chronic bronchitis MS Balter, J La Forge, DE Low, L Mandell, RF Grossman, ... Canadian respiratory journal 10 (suppl b), 3B-32B, 2003 | 169 | 2003 |
| Results of a phase III trial comparing tolevamer, vancomycin and metronidazole in patients with Clostridium difficile–associated diarrhea (CDAD) T Louie, M Gerson, D Grimard, S Johnson, A Poirier, K Weiss Proceedings of the 47th Annual Interscience Conference on Antimicrobial …, 2007 | 167 | 2007 |
| Human metapneumovirus infection in adults with community-acquired pneumonia and exacerbation of chronic obstructive pulmonary disease ME Hamelin, S Côtù, J Laforge, N Lampron, J Bourbeau, K Weiss, R Gilca, ... Clinical infectious diseases 41 (4), 498-502, 2005 | 155 | 2005 |
| A Nosocomial Outbreak of Fluoroquinolone-Resistant Streptococcus pneumoniae K Weiss, C Restieri, R Gauthier, M Laverdiere, A McGeer, RJ Davidson, ... Clinical Infectious Diseases 33 (4), 517-522, 2001 | 155 | 2001 |
| Importance of viral and bacterial infections in chronic obstructive pulmonary disease exacerbations G De Serres, N Lampron, J La Forge, I Rouleau, J Bourbeau, K Weiss, ... Journal of Clinical Virology 46 (2), 129-133, 2009 | 154 | 2009 |
| Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection which predicts response to therapy MA Miller, T Louie, K Mullane, K Weiss, A Lentnek, Y Golan, Y Kean, ... BMC infectious diseases 13, 1-7, 2013 | 152 | 2013 |
| Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non … RJ Vickers, GS Tillotson, R Nathan, S Hazan, J Pullman, C Lucasti, ... The Lancet infectious diseases 17 (7), 735-744, 2017 | 143 | 2017 |
| Clinical Characteristics at Initial Presentation and Impact of Dual Therapy on the Outcome of Bacteremic Streptococcus pneumoniae Pneumonia in Adults K Weiss, DE Low, L Cortes, A Beaupre, R Gauthier, P Gregoire, M Legare, ... Canadian respiratory journal 11, 589-593, 2004 | 140 | 2004 |
| Antimicrobial Resistance among Clinical Isolates of Streptococcus pneumoniae in Canada during 2000 DE Low, J de Azavedo, K Weiss, T Mazzulli, M Kuhn, D Church, ... Antimicrobial agents and chemotherapy 46 (5), 1295-1301, 2002 | 137 | 2002 |
| Comparative activity of new quinolones against 326 clinical isolates of Stenotrophomonas maltophilia K Weiss, C Restieri, E De Carolis, M Laverdière, H Guay Journal of antimicrobial Chemotherapy 45 (3), 363-365, 2000 | 127 | 2000 |
| Group A Streptococcus invasive infections: a review KA Weiss, M Laverdière Canadian journal of surgery 40 (1), 18, 1997 | 126 | 1997 |
| HIV-associated lipodystrophy syndrome: A review of clinical aspects JG Baril, P Junod, R LeBlanc, H Dion, R Therrien, F Laplante, J Falutz, ... Canadian Journal of Infectious Diseases and Medical Microbiology 16, 233-243, 2005 | 124 | 2005 |
